1[1]Zikos P, Van Lint MT, Frassoni F, et al. Low transplant mortality in allogeneic bone marrow transplantation for acute myleloid leukemia: a randomized study of low-dose cyclosporine versus low-dose cyclosporin and low-dose methotrexate[J]. Blood, 1998, 91: 3503-3508
2[2]Tomas ED. Bone marrow transplantation[J]. New Engl J Med, 1975, 292:895
3[3]Storb R, Deeg HJ, Fisher L, et al. Cyclosporine vs methotrexate for graft-vs-host disease prevention in patients given marrow graft for leukemia: long-term follow-up of three controlled trial[J]. Blood,1988,71: 293-298
4[4]Ashan J, Ringden O, Sundberg B, et al. Methotrexate combined with cyclosporine A decreases graft-versus-host disease, but increase leukemia relapse compared to monotherapy[J].Bone Marrow Transplant,1991,7:113-119
5[5]Ringden O, Horowitz MM, Sondel P, et al. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia[J]? Blood, 1993,81: 1094-1101
3Macdonald D, Aguiar RC, Mason P J, et al. A new myeloprolifera- tire disorder associated with chromosomal translocations involving 8pll: a review [J]. Leukemia, 1995, 9(10) : 1628 -1630.
4Jackson CC, Medeiros LJ, Miranda RN. 8pll myeloproliferative syndrome: a lview [J]. Hum Pathol, 2010, 41 (4) : 461 -476.
5Lewis ]P, lenks H, Lazerson J. Philadelphia chromosome-negative chronic myelogenous leukemia in a ehild with t( 8 ;9 ) (pl 1 or 12; q34) [J]. Am J Pediatr Hematol Oncol, 1983, 5 (3): 265 - 269.
6Nakayama H, Inamitsu T, Ohga S, et al. Chn)nic myelomonocytic leukaemia with t( 8 ; 9 ) ( pl 1 ; q34 ) in childhood : an example of the 8pl I myeloproliferative disorder? [ J]. Br J Haematol, 1996, 92 ( 3 ) : 692 - 695.
7Van den Berg H, Kroes W, van der Schoot CE, et al. A young child with acquired t ( 8 ;9 ) ( p l 1 ; q34) : additional proof that 8pl 1 is involved in mixed myeloid/T lymphoid malignancies [ J]- Leu- kemia, 1996, 10(7): 1252- 1253.
8Sohal J, Chase A, Mould S, et al. Identification of tbur new trans- locations involving FGFR1 in myeloid disorders [ J]. Genes Chro- mosomes Cancer, 2001, 32(2): 155- 163.
9Yamamoto K, Kawano H, Nishikawa S, et al. A biphenotypic transformation of 8pl I myeloproliferative syndrome with CEPI/FG- FRI fusion gene [J]. Eur J Haematol, 2006, 77(4) : 349 - 354.
10Suzan F, Guasch G, Terre C, et al. Long-term complete haemato- logical and molecular remission after allogeneie bone marrow trans- plantation in a patient wilh a stem cell myeloproliferative disorder associated with t (8 ; 13 ) ( p l 2 ; q12 ) [ J ]. Br J Haematol, 2003, 121(2): 312-314.
